Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -134.50 | 28.87 |
PEG Ratio (TTM) | -29.01 | 3.66 |
P/S Ratio (TTM) | 1.34 | 5.95 |
P/B Ratio (TTM) | 2.15 | 19.31 |
P/FCF Ratio (TTM) | 13.78 | 25.68 |
Price to 5YR AVG Earnings Ratio | N/A | 37.01 |
Price to 5YR AVG FCF Ratio | N/A | 32.85 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.48% | 9.01% |
ROE (TTM) | -1.56% | 75.53% |
Net Profit Margin (TTM) | -1.00% | 20.14% |
ROIC 5YR AVG | N/A | 58.24% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -48.04% | 273.05% | N/A |
Revenue | 0.00% | 9.69% | N/A |
Net Income | -46.25% | 274.95% | N/A |
Cash Flow | 111.95% | 96.83% | N/A |
Health (30%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.76 | 1.34 |
Quick Ratio (TTM) | 1.59 | 1.36 |
D/E Ratio (TTM) | 1.63 | 0.94 |
Interest Coverage (TTM) | 1.04 | 24.65 |
Piotroski F-Score | 3 | 8 |
Altman Z-Score | 1.04 | 3.68 |
LTL to 5YR AVG FCF | N/A | 3.10 |
Shares Outstanding Growth 5YR AVG | N/A | -0.48% |